Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for Dexamethasone
Perform Another (Advanced) Search
361 Results within Clinical Trial Listings
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
Displaying results 1—20
Next > Last »
1. Study Posting (1918) Trial #160138, Vomiting, Savannah, GA ...Study Posting (1918) Trial #160138, Vomiting, Savannah, GA Trial Information Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer URCC U1105 RATIONALE: Antiemetic drugs, such as granisetron, dexamethasone, prochlorperazine, aprepitant, and palonosetron, may help lessen or prevent nausea. It is not yet known ...View Page
2. Study Posting (1918) Trial #160137, Breast Cancer, Savannah, GA ...Study Posting (1918) Trial #160137, Breast Cancer, Savannah, GA Trial Information Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer URCC U1105 RATIONALE: Antiemetic drugs, such as granisetron, dexamethasone, prochlorperazine, aprepitant, and palonosetron, may help lessen or prevent nausea. It is not yet known ...View Page
3. Study Posting (180) Trial #88174, Multiple Myelomas, New York, NY ...Multiple Myelomas, New York, NY Trial Information Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Newly Diagnosed Multiple Myeloma. The purpose of this study is to compare the effects (good and bad) of dexamethasone (a steroid and a commonly used therapy for multiple myeloma) with dexamethasone + CC-5013 (an ...View Page
4. Study Posting (4519) Trial #124739, Idiopathic Thrombocytopenic Purpura (ITP), Verona, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
5. Study Posting (4519) Trial #123839, Idiopathic Thrombocytopenic Purpura (ITP), Udine, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
6. Study Posting (4519) Trial #125472, Idiopathic Thrombocytopenic Purpura (ITP), Taranto, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
7. Study Posting (4519) Trial #122575, Idiopathic Thrombocytopenic Purpura (ITP), Siena, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
8. Study Posting (4519) Trial #125574, Idiopathic Thrombocytopenic Purpura (ITP), Roma, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
9. Study Posting (4519) Trial #123831, Idiopathic Thrombocytopenic Purpura (ITP), Ravenna, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
10. Study Posting (4519) Trial #125014, Idiopathic Thrombocytopenic Purpura (ITP), Pescara, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
11. Study Posting (4519) Trial #125471, Idiopathic Thrombocytopenic Purpura (ITP), Pesaro, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
12. Study Posting (4519) Trial #147566, Idiopathic Thrombocytopenic Purpura (ITP), Pavia, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
13. Study Posting (4519) Trial #124695, Idiopathic Thrombocytopenic Purpura (ITP), Palermo, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
14. Study Posting (4519) Trial #125591, Idiopathic Thrombocytopenic Purpura (ITP), Padova, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
15. Study Posting (4519) Trial #125584, Idiopathic Thrombocytopenic Purpura (ITP), Napoli, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
16. Study Posting (4519) Trial #125534, Idiopathic Thrombocytopenic Purpura (ITP), Milano, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
17. Study Posting (4519) Trial #147730, Idiopathic Thrombocytopenic Purpura (ITP), Genova, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
18. Study Posting (4519) Trial #124367, Idiopathic Thrombocytopenic Purpura (ITP), Cuneo, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
19. Study Posting (4519) Trial #124365, Idiopathic Thrombocytopenic Purpura (ITP), Cagliari, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
20. Study Posting (4519) Trial #123309, Idiopathic Thrombocytopenic Purpura (ITP), Brescia, Italy ...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of first-line treatment with dexamethasone or dexamethasone plus MabThera on sustained treatment response in adult patients with idiopathic thrombocytopenic purpura Brief Summary ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.